Multiple Endocrine Neoplasia Type 2A Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for Multiple Endocrine Neoplasia Type 2A medications. A condition association alone does not establish coverage.
What Is Multiple Endocrine Neoplasia Type 2A?
Multiple Endocrine Neoplasia Type 2A is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing Multiple Endocrine Neoplasia Type 2A with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About Multiple Endocrine Neoplasia Type 2A
Multiple Endocrine Neoplasia Type 2A (MEN2A) is a rare genetic disorder characterized by the development of tumors in certain endocrine glands. Managing this condition often involves specialized and costly medications. TheDrugClub is dedicated to helping individuals and families with MEN2A access the critical treatments they need by offering significant savings on prescription drugs.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What is Multiple Endocrine Neoplasia Type 2A?
A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (carcinoma, medullary) of the thyroid gland, and usually with the co-occurrence of pheochromocytoma, producing calcitonin and adrenaline, respectively. Less frequently, it can occur with hyperplasia or adenoma of the parathyroid glands. This disease is due to gain-of-function mutations of the MEN2 gene on chromosome 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a receptor protein-tyrosine kinase. It is an autosomal dominant inherited disease.
Also called: MEA 2a, MEA II, Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma, Sipple Syndrome
Classified under: Multiple Endocrine Neoplasia
Source: Medical Subject Headings (MeSH), U.S. National Library of Medicine
Capitalization of MeSH cross-references in this definition was adjusted for readability. The U.S. National Library of Medicine does not endorse this change.
This information is educational and is not medical advice.